CVS Stock Recent News

Perhaps it's not all too surprising to witness the S&P 500 run into turbulence after two of the best years for stock gains in recent memory.

CVS Health (CVS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Healthcare conglomerate CVS Health has bid for a significant number of stores and patient data from bankrupt pharmacy chain operator Rite Aid, Bloomberg News reported on Thursday.

Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the CEO Andrew Witty also stepped down for ‘personal reasons.

The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.

CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.

Live Updates Live Coverage Has Ended Goldman's Warning 2:30 pm by Gerelyn Terzo Wall Street firm Goldman Sachs believes there’s still another shoe yet to drop in the trade wars despite progress made between the White House and Beijing. The analyst firm wrote: “The large reduction in the U.S. tariff rate on China should only have a limited impact on the overall U.S. effective tariff rate. After accounting for a reduction of that magnitude, the full set of U.S. tariffs would still be considerably higher and broader than expected by markets at the start of the year.” Winners & Losers 12:12 pm by Gerelyn Terzo With today’s market rally, the S&P 500 has narrowed its year-to-date declines to 1.3%. Within the S&P 500, today’s biggest gainers include NRG Energy (NYSE: NRG), up 23%, Stanley Black & Decker (NYSE: SWK), up 14.4%, and Microchip Tech (Nasdaq: MCHP), up 11.2%. Among the biggest losers of today’s session include Cigna Group (NYSE: CI),

NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.